Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Income towards Parent Company (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Income towards Parent Company readings, the most recent being -$2.1 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 8.14% to -$2.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.6 million, a 0.61% decrease, with the full-year FY2025 number at -$3.6 million, up 70.73% from a year prior.
  • Income towards Parent Company hit -$2.1 million in Q1 2026 for Neuroone Medical Technologies, down from -$1.4 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.8 million in Q4 2024 to a low of -$3.5 million in Q1 2023.
  • Median Income towards Parent Company over the past 5 years was -$2.8 million (2022), compared with a mean of -$2.3 million.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 153.37% in 2024 and later tumbled 180.54% in 2025.
  • Neuroone Medical Technologies' Income towards Parent Company stood at -$1.7 million in 2022, then tumbled by 93.04% to -$3.3 million in 2023, then skyrocketed by 153.37% to $1.8 million in 2024, then tumbled by 180.54% to -$1.4 million in 2025, then crashed by 45.05% to -$2.1 million in 2026.
  • The last three reported values for Income towards Parent Company were -$2.1 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.6 million (Q3 2025) per Business Quant data.